-
1
-
-
84923007306
-
Evaluation of environmental risk factors for prostate cancer in a population of Iranian patients
-
PID: 25605146
-
Pouresmaeili F, Hosseini SJ, Farzaneh F et al (2014) Evaluation of environmental risk factors for prostate cancer in a population of Iranian patients. Asian Pac J Cancer Prev 15:10603–10605
-
(2014)
Asian Pac J Cancer Prev
, vol.15
, pp. 10603-10605
-
-
Pouresmaeili, F.1
Hosseini, S.J.2
Farzaneh, F.3
-
2
-
-
77952878196
-
Defining and treating high-risk prostate cancer: can we do better?
-
PID: 20363552
-
Gerber L, Banez LL, Freedland SJ (2010) Defining and treating high-risk prostate cancer: can we do better? Eur Urol 58:8–9
-
(2010)
Eur Urol
, vol.58
, pp. 8-9
-
-
Gerber, L.1
Banez, L.L.2
Freedland, S.J.3
-
3
-
-
22144484150
-
Androgen deprivation therapy for prostate cancer
-
COI: 1:CAS:528:DC%2BD2MXmtlSlt7g%3D, PID: 16014598
-
Sharifi N, Gulley JL, Dahut WL (2005) Androgen deprivation therapy for prostate cancer. Jama 294:238–244
-
(2005)
Jama
, vol.294
, pp. 238-244
-
-
Sharifi, N.1
Gulley, J.L.2
Dahut, W.L.3
-
4
-
-
84905089818
-
Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics
-
COI: 1:CAS:528:DC%2BC2cXht1KisL%2FL, PID: 24452758
-
Mukherji D, Omlin A, Pezaro C, Shamseddine A, de Bono J (2014) Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics. Cancer Metastasis Rev 33:555–566
-
(2014)
Cancer Metastasis Rev
, vol.33
, pp. 555-566
-
-
Mukherji, D.1
Omlin, A.2
Pezaro, C.3
Shamseddine, A.4
de Bono, J.5
-
5
-
-
84885926441
-
Novel therapeutic approaches for the treatment of castration-resistant prostate cancer
-
COI: 1:CAS:528:DC%2BC3sXhsleqsLzF, PID: 23792785
-
Heidegger I, Massoner P, Eder IE et al (2013) Novel therapeutic approaches for the treatment of castration-resistant prostate cancer. J Steroid Biochem Mol Biol 138:248–256
-
(2013)
J Steroid Biochem Mol Biol
, vol.138
, pp. 248-256
-
-
Heidegger, I.1
Massoner, P.2
Eder, I.E.3
-
6
-
-
1042302005
-
The STATs of cancer–new molecular targets come of age
-
COI: 1:CAS:528:DC%2BD2cXhtlaqtb0%3D
-
Yu H, Jove R (2004) The STATs of cancer–new molecular targets come of age. Nature Rev Cancer 4:97–105
-
(2004)
Nature Rev Cancer
, vol.4
, pp. 97-105
-
-
Yu, H.1
Jove, R.2
-
7
-
-
0035902180
-
Oncogenic kinase signalling
-
COI: 1:CAS:528:DC%2BD3MXktVSjsr0%3D, PID: 11357143
-
Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355–365
-
(2001)
Nature
, vol.411
, pp. 355-365
-
-
Blume-Jensen, P.1
Hunter, T.2
-
8
-
-
0038673854
-
StAT signaling in cancer: insights into pathogenesis and treatment strategies
-
COI: 1:CAS:528:DC%2BD3sXnt12gsLw%3D, PID: 12613201
-
Frank DA (2003) StAT signaling in cancer: insights into pathogenesis and treatment strategies. Cancer Treat Res 115:267–291
-
(2003)
Cancer Treat Res
, vol.115
, pp. 267-291
-
-
Frank, D.A.1
-
9
-
-
84868693885
-
Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
-
COI: 1:CAS:528:DC%2BC38XhvVKqu73O, PID: 23103770
-
Subramaniam A, Shanmugam MK, Perumal E et al (2013) Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta 1835:46–60
-
(2013)
Biochim Biophys Acta
, vol.1835
, pp. 46-60
-
-
Subramaniam, A.1
Shanmugam, M.K.2
Perumal, E.3
-
10
-
-
84893429662
-
Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors
-
COI: 1:CAS:528:DC%2BC2cXmt1agu7Y%3D, PID: 24388873
-
Siveen KS, Sikka S, Surana R et al (2014) Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta 1845:136–154
-
(2014)
Biochim Biophys Acta
, vol.1845
, pp. 136-154
-
-
Siveen, K.S.1
Sikka, S.2
Surana, R.3
-
11
-
-
84957612113
-
Targeting transcription factor STAT3 for cancer prevention and therapy
-
Chai EZ, Shanmugam MK, Arfuso F et al (2015) Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacol Ther. doi:10.1016/j.pharmthera.2015.10.004
-
(2015)
Pharmacol Ther
-
-
Chai, E.Z.1
Shanmugam, M.K.2
Arfuso, F.3
-
12
-
-
0017143525
-
Cardamonin and alpinetin from the seeds of Amomum subulatum
-
COI: 1:STN:280:DyaE283mvF2qsA%3D%3D, PID: 959382
-
Bheemasankara Rao C, Namosiva Rao T, Suryaprakasam S (1976) Cardamonin and alpinetin from the seeds of Amomum subulatum. Planta Med 29:391–392
-
(1976)
Planta Med
, vol.29
, pp. 391-392
-
-
Bheemasankara Rao, C.1
Namosiva Rao, T.2
Suryaprakasam, S.3
-
13
-
-
84862811331
-
Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-gamma/LPS-stimulated BV2 microglia via NF-kappaB signalling pathway
-
COI: 1:CAS:528:DC%2BC38Xit12ht7o%3D, PID: 22306767
-
Chow YL, Lee KH, Vidyadaran S et al (2012) Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-gamma/LPS-stimulated BV2 microglia via NF-kappaB signalling pathway. Int Immunopharmacol 12:657–665
-
(2012)
Int Immunopharmacol
, vol.12
, pp. 657-665
-
-
Chow, Y.L.1
Lee, K.H.2
Vidyadaran, S.3
-
14
-
-
33748490486
-
The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages
-
COI: 1:CAS:528:DC%2BD28XptlSlsbY%3D, PID: 16894344
-
Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R (2006) The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br J Pharmacol 149:188–198
-
(2006)
Br J Pharmacol
, vol.149
, pp. 188-198
-
-
Hatziieremia, S.1
Gray, A.I.2
Ferro, V.A.3
Paul, A.4
Plevin, R.5
-
15
-
-
29244443231
-
Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera
-
COI: 1:CAS:528:DC%2BD28XhslCjsQ%3D%3D, PID: 16183703
-
Lee JH, Jung HS, Giang PM et al (2006) Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. J Pharmacol Exp Ther 316:271–278
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 271-278
-
-
Lee, J.H.1
Jung, H.S.2
Giang, P.M.3
-
16
-
-
80052960367
-
Hybrid flavan-chalcones, aromatase and lipoxygenase inhibitors, from Desmos cochinchinensis
-
COI: 1:CAS:528:DC%2BC3MXhtF2qsrjN, PID: 21802698
-
Bajgai SP, Prachyawarakorn V, Mahidol C, Ruchirawat S, Kittakoop P (2011) Hybrid flavan-chalcones, aromatase and lipoxygenase inhibitors, from Desmos cochinchinensis. Phytochemistry 72:2062–2067
-
(2011)
Phytochemistry
, vol.72
, pp. 2062-2067
-
-
Bajgai, S.P.1
Prachyawarakorn, V.2
Mahidol, C.3
Ruchirawat, S.4
Kittakoop, P.5
-
17
-
-
36148998010
-
Cytotoxic chalcones and antioxidants from the fruits of a Syzygium samarangense (Wax Jambu)
-
COI: 1:CAS:528:DC%2BD2sXhtlCntLfO, PID: 22359426
-
Simirgiotis MJ, Adachi S, To S et al (2008) Cytotoxic chalcones and antioxidants from the fruits of a Syzygium samarangense (Wax Jambu). Food Chem 107:813–819
-
(2008)
Food Chem
, vol.107
, pp. 813-819
-
-
Simirgiotis, M.J.1
Adachi, S.2
To, S.3
-
18
-
-
76749118898
-
Cardamonin is a bifunctional vasodilator that inhibits Ca(v)1.2 current and stimulates K(Ca)1.1 current in rat tail artery myocytes
-
COI: 1:CAS:528:DC%2BC3cXltVCkt74%3D, PID: 19923439
-
Fusi F, Cavalli M, Mulholland D et al (2010) Cardamonin is a bifunctional vasodilator that inhibits Ca(v)1.2 current and stimulates K(Ca)1.1 current in rat tail artery myocytes. J Pharmacol Exp Ther 332:531–540
-
(2010)
J Pharmacol Exp Ther
, vol.332
, pp. 531-540
-
-
Fusi, F.1
Cavalli, M.2
Mulholland, D.3
-
19
-
-
80051684818
-
Cardamonin stimulates glucose uptake through translocation of glucose transporter-4 in L6 myotubes
-
COI: 1:CAS:528:DC%2BC3MXptlyqtbk%3D, PID: 21305634
-
Yamamoto N, Kawabata K, Sawada K et al (2011) Cardamonin stimulates glucose uptake through translocation of glucose transporter-4 in L6 myotubes. Phytother Res 25:1218–1224
-
(2011)
Phytother Res
, vol.25
, pp. 1218-1224
-
-
Yamamoto, N.1
Kawabata, K.2
Sawada, K.3
-
20
-
-
84930673499
-
Cardamonin inhibits metastasis of lewis lung carcinoma cells by decreasing mTOR activity
-
PID: 25996501
-
Niu PG, Zhang YX, Shi DH, Liu Y, Chen YY, Deng J (2015) Cardamonin inhibits metastasis of lewis lung carcinoma cells by decreasing mTOR activity. PloS One 10:e0127778
-
(2015)
PloS One
, vol.10
-
-
Niu, P.G.1
Zhang, Y.X.2
Shi, D.H.3
Liu, Y.4
Chen, Y.Y.5
Deng, J.6
-
21
-
-
84857236804
-
Cardamonin exerts potent activity against multiple myeloma through blockade of NF-kappaB pathway in vitro
-
COI: 1:CAS:528:DC%2BC38XivVOrt7g%3D, PID: 22226224
-
Qin Y, Sun CY, Lu FR et al (2012) Cardamonin exerts potent activity against multiple myeloma through blockade of NF-kappaB pathway in vitro. Leuk Res 36:514–520
-
(2012)
Leuk Res
, vol.36
, pp. 514-520
-
-
Qin, Y.1
Sun, C.Y.2
Lu, F.R.3
-
22
-
-
84878869508
-
Cardamonin suppresses the proliferation of colon cancer cells by promoting beta-catenin degradation
-
COI: 1:CAS:528:DC%2BC3sXhtlWlt7bI, PID: 23538439
-
Park S, Gwak J, Han SJ, Oh S (2013) Cardamonin suppresses the proliferation of colon cancer cells by promoting beta-catenin degradation. Biol Pharm Bull 36:1040–1044
-
(2013)
Biol Pharm Bull
, vol.36
, pp. 1040-1044
-
-
Park, S.1
Gwak, J.2
Han, S.J.3
Oh, S.4
-
23
-
-
84894640317
-
Antiproliferative activity and induction of apoptosis in PC-3 cells by the chalcone cardamonin from Campomanesia adamantium (Myrtaceae) in a bioactivity-guided study
-
PID: 24514747
-
Pascoal AC, Ehrenfried CA, Lopez BG et al (2014) Antiproliferative activity and induction of apoptosis in PC-3 cells by the chalcone cardamonin from Campomanesia adamantium (Myrtaceae) in a bioactivity-guided study. Molecules 19:1843–1855
-
(2014)
Molecules
, vol.19
, pp. 1843-1855
-
-
Pascoal, A.C.1
Ehrenfried, C.A.2
Lopez, B.G.3
-
24
-
-
79960897861
-
Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model
-
COI: 1:CAS:528:DC%2BC3MXpt1yhsro%3D, PID: 21480220
-
Shanmugam MK, Manu KA, Ong TH et al (2011) Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer 129:1552–1563
-
(2011)
Int J Cancer
, vol.129
, pp. 1552-1563
-
-
Shanmugam, M.K.1
Manu, K.A.2
Ong, T.H.3
-
25
-
-
0032499801
-
Three-dimensional structure of the Stat3beta homodimer bound to DNA
-
COI: 1:CAS:528:DyaK1cXksFynsr4%3D, PID: 9671298
-
Becker S, Groner B, Muller CW (1998) Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394:145–151
-
(1998)
Nature
, vol.394
, pp. 145-151
-
-
Becker, S.1
Groner, B.2
Muller, C.W.3
-
26
-
-
84910007055
-
Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells
-
COI: 1:CAS:528:DC%2BC2cXhsVaku7fM, PID: 25130169
-
Kim SM, Lee JH, Sethi G et al (2014) Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells. Cancer Lett 354:153–163
-
(2014)
Cancer Lett
, vol.354
, pp. 153-163
-
-
Kim, S.M.1
Lee, J.H.2
Sethi, G.3
-
27
-
-
84873908235
-
Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects
-
Shodeinde AL, Barton BE (2012) Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects. Oncotargets Ther 5:119–125
-
(2012)
Oncotargets Ther
, vol.5
, pp. 119-125
-
-
Shodeinde, A.L.1
Barton, B.E.2
-
28
-
-
0034722896
-
STAT proteins: novel molecular targets for cancer drug discovery
-
COI: 1:CAS:528:DC%2BD3MXhsF2rsro%3D, PID: 11426647
-
Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19:6613–6626
-
(2000)
Oncogene
, vol.19
, pp. 6613-6626
-
-
Turkson, J.1
Jove, R.2
-
29
-
-
32144453842
-
JAK/STAT signal transduction: regulators and implication in hematological malignancies
-
COI: 1:CAS:528:DC%2BD28XhtlKmt70%3D, PID: 16426581
-
Valentino L, Pierre J (2006) JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 71:713–721
-
(2006)
Biochem Pharmacol
, vol.71
, pp. 713-721
-
-
Valentino, L.1
Pierre, J.2
-
30
-
-
16344380754
-
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
-
COI: 1:CAS:528:DC%2BD2MXjt1Oiu78%3D, PID: 15781862
-
Song H, Wang R, Wang S, Lin J (2005) A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci USA 102:4700–4705
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 4700-4705
-
-
Song, H.1
Wang, R.2
Wang, S.3
Lin, J.4
-
31
-
-
84952874601
-
) Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells
-
Wu N, Liu J, Zhao X et al (2015) Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells. Tumour Biol. doi:10.1007/s13277-015-3673-y
-
(2015)
Tumour Biol
-
-
Wu, N.1
Liu, J.2
Zhao, X.3
-
32
-
-
85009494895
-
Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
-
Jia D, Tan Y, Liu H et al. (2015) Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo. Oncotarget
-
(2015)
Oncotarget
-
-
Jia, D.1
Tan, Y.2
Liu, H.3
-
33
-
-
33947574564
-
Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution
-
COI: 1:CAS:528:DC%2BD2sXjsFShu7g%3D, PID: 17341611
-
Aggarwal BB, Sethi G, Ahn KS et al (2006) Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091:151–169
-
(2006)
Ann N Y Acad Sci
, vol.1091
, pp. 151-169
-
-
Aggarwal, B.B.1
Sethi, G.2
Ahn, K.S.3
-
34
-
-
80052197203
-
Small molecule inhibitors of STAT3 for cancer therapy
-
COI: 1:CAS:528:DC%2BC3MXht1KjsbrJ, PID: 21824090
-
Zhao M, Jiang B, Gao FH (2011) Small molecule inhibitors of STAT3 for cancer therapy. Curr Med Chem 18:4012–4018
-
(2011)
Curr Med Chem
, vol.18
, pp. 4012-4018
-
-
Zhao, M.1
Jiang, B.2
Gao, F.H.3
-
35
-
-
84958811619
-
Cardamonin inhibited cell viability and tumorigenesis partially through blockade of testes-specific protease 50-mediated nuclear factor-kappaB signaling pathway activation
-
COI: 1:CAS:528:DC%2BC28XivVGrs70%3D, PID: 26855338
-
Mi XG, Song ZB, Sun LG et al (2016) Cardamonin inhibited cell viability and tumorigenesis partially through blockade of testes-specific protease 50-mediated nuclear factor-kappaB signaling pathway activation. Int J Biochem Cell Biol 73:63–71
-
(2016)
Int J Biochem Cell Biol
, vol.73
, pp. 63-71
-
-
Mi, X.G.1
Song, Z.B.2
Sun, L.G.3
-
36
-
-
85009487706
-
Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
-
PID: 26506421
-
Jia D, Tan Y, Liu H et al (2016) Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo. Oncotarget 7:771–785
-
(2016)
Oncotarget
, vol.7
, pp. 771-785
-
-
Jia, D.1
Tan, Y.2
Liu, H.3
|